We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

20 hedge funds and large institutions have $1.27M invested in Cocrystal Pharma in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

43% more funds holding

Funds holding: 14 → 20 (+6)

0.44% more ownership

Funds ownership: 6.63% → 7.07% (+0.44%)

19% less capital invested

Capital invested by funds: $1.57M → $1.27M (-$305K)

Holders
20
Holders Change
+6
Holders Change %
+42.86%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Parallel Advisors
California
+$29.6K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$27.4K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$24.8K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.78K
5
UBS Group
UBS Group
Switzerland
+$1.77K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$1.83K
2
JP Morgan Chase
JP Morgan Chase
New York
-$33
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$485K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$229K +$389 +200 +0.2%
BlackRock
3
BlackRock
New York
$130K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$117K +$2.78K +1,428 +2%
Morgan Stanley
5
Morgan Stanley
New York
$104K – – –
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$66.5K +$24.8K +12,748 +51%
State Street
7
State Street
Massachusetts
$36.2K – – –
PA
8
Parallel Advisors
California
$26.8K +$29.6K +15,228 New
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$24.8K +$27.4K +14,092 New
Northern Trust
10
Northern Trust
Illinois
$21.4K – – –
Bank of America
11
Bank of America
North Carolina
$15.9K +$33 +17 +0.2%
TRCT
12
Tower Research Capital (TRC)
New York
$4.83K -$1.83K -938 -25%
UBS Group
13
UBS Group
Switzerland
$1.6K +$1.77K +910 New
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$1.44K +$1.59K +817 New
CYG
15
Clean Yield Group
Vermont
$736 +$814 +418 New
JP Morgan Chase
16
JP Morgan Chase
New York
$723 -$33 -17 -4%
NL
17
NVWM LLC
Pennsylvania
$148 – – –
Osaic Holdings
18
Osaic Holdings
Arizona
$29 +$33 +17 New
AWM
19
Activest Wealth Management
Florida
$2 – – –

COCP Hedge Fund Activity: Q3 2024 in Review

20 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q3 2024, worth a combined $1.27M — down 19% from $1.57M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new COCP positions and 0 closed out — a net gain of 6 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Parallel Advisors, opening a new position worth an estimated $29.6K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.83K.

  • 20 institutional investors held Cocrystal Pharma (COCP) as of Q3 2024, up from 14 in Q2 2024.
  • Funds reported $1.27M of Cocrystal Pharma stock for Q3 2024, down 19% quarter-over-quarter.
  • 6 funds opened new Cocrystal Pharma positions in Q3 2024 and 0 closed out, a net change of +6 holders.
  • The largest Cocrystal Pharma buyer in Q3 2024 was Parallel Advisors, an estimated $29.6K added.
  • The largest Cocrystal Pharma seller in Q3 2024 was Tower Research Capital (TRC), an estimated $1.83K sold.

Based on aggregated 13F filings for Q3 2024.